Pharmacokinetics of Long-Acting Tenofovir Alafenamide (GS-7340) Subdermal Implant for HIV Prophylaxis

Oral or topical daily administration of antiretroviral (ARV) drugs to HIV-1-negative individuals in vulnerable populations is a promising strategy for HIV-1 prevention. Adherence to the dosing regimen has emerged as a critical factor determining efficacy outcomes of clinical trials. Because adherenc...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:Antimicrob Agents Chemother
Glavni autori: Gunawardana, Manjula, Remedios-Chan, Mariana, Miller, Christine S., Fanter, Rob, Yang, Flora, Marzinke, Mark A., Hendrix, Craig W., Beliveau, Martin, Moss, John A., Smith, Thomas J., Baum, Marc M.
Format: Artigo
Jezik:Inglês
Izdano: American Society for Microbiology 2015
Teme:
Experimental Therapeutics
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC4468692/
https://ncbi.nlm.nih.gov/pubmed/25896688
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.00656-15
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items